Engineering human biology to redefine neurologic drug discovery

Modeling neuroinflammatory diseases with advanced in vitro models

Explore

Stem Pharm’s Offerings

  • Human Neural Organoids

    Physiologically relevant organoids featuring microglia for neuroimmune drug discovery.

    Explore

  • Drug Discovery Services & Partnerships

    Neurologic disease modeling, target discovery, phenotypic drug screening, and neurotoxicity assessments.

    Explore

  • Synthetic Substrates

    Chemically-defined hydrogels and pre-coated cell culture plates that improve outcomes for cell-based applications.

    Explore

Partner with Stem Pharm

Our team of experienced scientists will design and execute studies that will generate new insights and increase your confidence to move programs forward.

Together, let’s generate results.

Recent News

  • Stem Pharm featured in FOX6 News Milwaukee

    The news piece spotlighted Stem Pharm’s cutting-edge work in human neuro-immune organoids and Alzheimer’s drug discovery.

    Watch the full feature

  • Steve Visuri, CEO, featured in Open Record podcast

    As a follow-up to the recent FOX6 News Milwaukee feature, Steve Visuri, CEO, sat down with the Open Record podcast, hosted by FOX6 reporters, to dive deeper into the topics raised in the news piece. They talked about Stem Pharm’s human neural organoid platform, its application to Stem Pharm’s Alzheimer’s drug discovery program, and how this research supports the growing movement to reduce animal testing in drug development.

    Listen here

  • Neuroscience 2025

    Connect with us at Neuroscience 2025 in San Diego, Nov. 11-15.

    Read more